Literature DB >> 23757346

Spermidine-cross-linked hydrogels as novel potential platforms for pharmaceutical applications.

Rita López-Cebral1, Patrizia Paolicelli, Vanessa Romero-Caamaño, Begoña Seijo, Maria Antonietta Casadei, Alejandro Sanchez.   

Abstract

Endogen polyamines are known to be molecules of high biological value. Herein, a new generation of physical hydrogels was developed through the mild ionotropic gelantion technique, using the endogen polyamine spermidine as a physical cross-linker. The main negatively charged polymer of the hydrogel is the natural polysaccharide gellan gum. Optionally, interesting endogen molecules, such as chondroitin sulfate and albumin, can be included as part of the formulation. These new hydrogels were characterized and the influence of the different components on their final properties was carefully analyzed, ultimately demonstrating the possibility to modulate these properties as well as the system's versatility in terms of composition. On the contrary, in vitro cell studies showed the absence of cytotoxicity of these hydrogels. Finally, the in vitro-release profiles obtained for different model molecules evidenced the potential of these systems as novel drug delivery platforms.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  drug delivery; hydrogels; polycations; polysaccharides; proteins; spermidine

Mesh:

Substances:

Year:  2013        PMID: 23757346     DOI: 10.1002/jps.23631

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Spermidine Crosslinked Gellan Gum-Based "Hydrogel Nanofibers" as Potential Tool for the Treatment of Nervous Tissue Injuries: A Formulation Study.

Authors:  Barbara Vigani; Caterina Valentino; Giuseppina Sandri; Carla Marcella Caramella; Franca Ferrari; Silvia Rossi
Journal:  Int J Nanomedicine       Date:  2022-08-02

2.  Extraction and Characterization of Collagen from Elasmobranch Byproducts for Potential Biomaterial Use.

Authors:  Manuel J Seixas; Eva Martins; Rui L Reis; Tiago H Silva
Journal:  Mar Drugs       Date:  2020-12-04       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.